SC to govt: Why can’t SMA med be as cheap in India as in Pakistan, China? – The Times of India
In India, a bottle of Risdiplam costs Rs 6.2 lakh, whereas in Pakistan it is around Rs 41,000 per bottle and in China Rs 44,692 NEW DELHI: A unique argument – if the medicine for treatment of spinal muscular atrophy (SMA) is cheaper in Pakistan and China, why can’t it be similarly priced to help…